Johnson & Johnson (JNJ) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in ...

Fourpath Capital Management LLC decreased its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 20.0% in ...

Rockline Wealth Management LLC boosted its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 5.5% in the fourth ...

Dividend growth stocks offer a balance of stability and compounding returns, and here are three standout companies with ...

Sarat Sethi, DCLA managing partner, joins 'Squawk Box' to discuss the latest market trends, his top stock picks, and more.

Johnson & Johnson's Q4 2024 earnings missed EPS expectations, but broadly met revenue targets. Click here to read why JNJ stock is a Buy.

Johnson & Johnson (NYSE: JNJ) is one of the world's largest and most prominent healthcare leaders. Furthermore, revenue ...

UPS and JNJ present strong dividends and attractive valuations. See why these durable companies are great for a buy-and-hold ...

Johnson & Johnson ( JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to ...

Multinational healthcare company Johnson & Johnson (NYSE:JNJ) met Wall Street’s revenue expectations in Q4 CY2024, with sales ...

Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year. Despite strong performances from other pharmaceutical giants ...